Epidermal growth factor (EGF) has been shown to stimulate in vitro growth of epithelial cells derived both from normal breast and mammary carcinomas . A prerequisite for the growth promoting effect of EGF seems to be the presence of a cellular receptor for EGF (Heldin & Westermark, 1984) . Plasma membrane receptors have been found in approximately 40% of biopsies from human breast carcinomas (Perez et al., 1984;. The amount of EGF bound varied between 1-121 fmol mg-1 membrane protein . The significance of cellular EGF receptor content with respect to tumour cell differentiation and growth is at present obscure. However there seems to be an inverse relationship between the receptors for EGF and oestrogen (Peirez et al., 1984;. Since high levels of oestrogen receptors are found in well differentiated breast carcinomas (Erhardt et al. to be published) it is tempting to speculate that detectable levels of the EGF receptor are confined to poorly differentiated carcinomas.
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The activity of thymidine kinase-1 (Tk-1) has been found to increase when cells enter the S phase (Adler & McAuslan, 1974 Tumour cytosol and membrane fractions were prepared from -1 g tumour tissue. After homogenization in 5 ml of buffer (5 mM NaPO4, pH 7.4, 1 mm DTT and 10% glycerol) using a Polytron with intermittent bursts of 15 sec each, an aliquot was withdrawn for measurements of total DNA using the method of Burton (1956) . The homogenate was then centrifuged at 100,000g for 40min at 0°C. The resulting supernatant was used for ER analysis and thymidine kinase determination. The pellet was resuspended in 1O mm Tris HCl, pH 7.4, the suspension was recentrifuged at 100,000g for 60min at 0°C and the resulting pellet was used for EGF receptor binding. Single cell DNA measurements were performed on imprint specimens from thawed tumour material. These specimens were fixed, hydrolyzed and stained with acriflavine-SO2, and the DNA quantitation was made in a Leitz MPV3 cytophotometer. The technical details of preparation and analysis have *been described previously (Bjelkenkrantz, 1983) . In each sample more than 150 tumour cell nuclei were selected and their DNA content measured.
Histograms showing the distribution of DNA content in the cells were constructed for each case, as suggested by Auer et al. (1980) . Differences in tumour aggressiveness were small in between types I/II and types III/IV, therefore, in the present study only two groups were distinguished. Euploid tumours consisting of cases where the DNA histograms show a distinct peak at the normal diploid or at the tetraploid DNA value, or both, with only a few cells outside the range of these peaks. Aneuploid tumours consisting of cases with a sizeable number of cells outside the diploid-tetraploid peaks, or cases that show an irregular or aneuploid distribution of DNA in the nuclei.
Statistical analysis
The Chi-square test was used.
Material sources Mouse epidermal growth factor (EGF) was isolated from mouse submaxillary glands as described by Savage & Cohen (1972) . EGF was iodinated by the chloramine T method (Hunter & Greenwood, 1962 The EGF-R values ranged between 0 to 80 amol-P1 g DNA and only one tumour had a value over 50 amol g1-I DNA.
EGF-R in different histological subclasses
The most common subclass of human mammary carcinomas is that of the ductal type. Analysis of [125I]-EGF binding to 22 tumours of this subtype is presented in Table I . This table shows that 8 had high affinity binding sites for the growth factor while 14 had no detectable receptors.
Carcinomas of the classical medullary type are found infrequently and only 2 cases were available for analysis. Both tumours had high affinity receptors for EGF (Table I) .
Two sub-groups, pure colloid and lobular carcinomas, did not contain any measurable EGF-R.
Fibroadenomas are benign tumours of lobular origin. Three such tumours were analyzed for EGF-R and all three were found to be negative (Table I) . (Figure 2) .
The two medullary carcinomas were both aneuploid and contained detectable levels of EGF-R.
Among the lobular carcinomas 5 were euploid and 4 aneuploid. However, as previously described all these tumours were negative for EGF binding (Figure 2 ).
All three fibroadenomas were euploid and lacked the EGF-R (data not shown).
Receptors for oestradiol and EGF It has previously been described that EGF-R containing tumours often had a low cellular content of oestradiol receptors (ER) (Perez et al., 1984; . As can be seen from Figure I all but one tumour with detectable EGF-R had ER levels below 0.4fmolHg-1 DNA (P<0.05). Thymidine kinase activity and EGF-R The cellular level of the thymidine kinase isoenzyme with an IP of 8.5 has been found to be increased in cells engaged in DNA synthesis (Adler & McAuslan, 1974; Nordenskjold et al., 1970) . It therefore seems likely that measurements of this enzyme will give an estimate of the proliferative activity of the tumours. It was therefore considered of interest to study the level of this enzyme in human mammary carcinomas with respect to EGF-R. The results from analysis of 37 carcinomas are depicted in Figure 3 which shows that there was no correlation between the cellular content of thymidine kinase and EGF-R. No correlation was found between thymidine kinase activity and morphological subtype.
Thymidine kinase and DNA pattern Mammary carcinomas with an euploid DNA pattern have been suggested to represent a group of tumours with a low growth rate as compared to that of aneuploid carcinomas (Erhardt et al., to be published). We therefore analyzed the relation between thymidine kinase and DNA pattern in the 37 different mammary carcinomas described above plus 10 others. Figure 4 shows that the cellular levels of thymidine kinase were significantly higher (P= 0.05) in the aneuploid tumours that in the euploid ones. Thus the mean value for euploid tumours was 6.4pmol pg-1 DNA as compared to 14.6pmolpg-1 DNA in the aneuploid group.
However, there was a considerable overlap between the thymidine kinase values in the two groups.
Discussion
EGF has been shown to have a mitogenic effect on breast cancer cells in vitro (Perez et al., 1984; (Perez et al., 1984) . The absence of EGF-R in lobular carcinomas is of interest. We have previously reported that lobular carcinomas differ from ductal carcinomas with respect to cellular content of ER and receptors for vitamin A (Skoog et al., 1985) . Thus ductal and lobular carcinomas appear to have different capacities for regulation by several growth factors as EGF, vitamin A and oestradiol.
Colloid carcinomas also lacked EGF-R. It is suggested that colloid carcinomas represent a highly differentiated ductal tumour. It is tempting to speculate that the low degree of malignancy which is a hall-mark of colloid cancers may in some way be related to the absence of EGF-R (Silverberg et al., 1971) . However, the number of tumours studied is small and our data should be interpreted cautiously.
The absence of detectable levels of EGF-R in fibroadenomas may seem puzzling for two reasons. First, primary cultures of fibroadenomas are induced to proliferate by EGF (Stoker et al., 1976) . Second, fibroblasts in tissue culture have detectable EGF-R. However, it is possible that this discrepancy may result from the comparison of an in vivo with an in vivo situation with different levels of EGF-R expression. The affinity for EGF in fibroblasts seems to be comparatively low, which may also contribute to our results (Sainsbury et al., 1985) .
In line with reports by others we found that cells with measurable EGF-R tended to have a low level of cytoplasmic ER (Perez et al., 1984; Sainsbury et al., 1985) . In the present material this finding could be partly explained by the fact that approximately 50% of these tumours were obtained from premenopausal women. It is well documented that premenopausal women have low ER in their tumours since endogenously produced oestradiol will block the receptor (Theve et al., 1978) .
The absence of detectable EGF-R in some tumours can be explained in several ways. In the first place as a result of transformation EGF-R expression is induced or increased in tumour cells. This mechanism has been suggested for gliomas but does not appear to be a general phenomenon (Libermann et al., 1984; Cherington et al., 1979; Hollenberg et al., 1979) . Secondly, some tumours might be exposed to endogenous EGF or related peptides such as TGF -a which then leads to a masking/down regulation of the receptor (Heldin & Westermark, 1984) . A third possibility is that expression of EGF-R is present in all normal cells and that this phenotype sometimes is lost as a result of malignant transformation. In the latter case one would assume that poorly differentiated carcinomas should lack EGF-R more often. This does not seem to be the case since in our study EGF-R was present in both euploid and aneuploid tumours albeit in slightly different proportions.
We were also unable to find any correlation between EGF-R levels and the proliferative activity as measured by cellular content of thymidine kinase isoenzyme with p18.5. This isoenzyme increases in S phase and thus correlates with the proportion of cells synthesizing DNA (Adler & McAuslan, 1974; Nordenskjdld et al., 1970) . The expression of EGF-R does not seem to be the result of a low/high growth rate in the tumours. Moreover this lack of correlation between receptor and proliferative activity also seems to rule out the possibility that the low levels of EGF-R result from an endogenous binding of mitogenic growth factors. The difference in EGF-R levels between morphological subgroups might therefore represent true biological differences. The clinical relevance of such a difference remains to be elucidated. A second finding of interest is that the activity of thymidine kinase tended to be higher in tumours with an aneuploid DNA pattern as compared to those with an euploid pattern. This is in line with the proposed high proliferative activity in aneuploid tumours (Bjelkenkrantz et al., to be published). The relevance of this observation with respect to tumour aggressiveness and clinical course of the disease needs to be further studied.
In conclusion, our data suggest that EGF-R positivity is confined only to certain subgroups of mammary carcinomas. This finding is of interest when considering growth regulation of mammary tumours as well as the possible use of EGF-R as a prognostic indicator.
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